Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ · Healthcare
Monte Rosa Therapeutics, Inc. Total Liabilities 2023–2025
Monte Rosa Therapeutics, Inc. annual/quarterly total liabilities history from 2023 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Monte Rosa Therapeutics, Inc. total liabilities for the quarter ending December 31, 2025 were 215.6M, a 0.09% decrease year-over-year.
- Monte Rosa Therapeutics, Inc. total liabilities for 2025 were 215.6M, a 0.09% decrease from 2024.
- Monte Rosa Therapeutics, Inc. total liabilities for 2024 were 215.8M, a 73.32% increase from 2023.
- Monte Rosa Therapeutics, Inc. total liabilities for 2023 were 124.5M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Monte Rosa Therapeutics, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $216 |
| 2024 | $216 |
| 2023 | $125 |
| Monte Rosa Therapeutics, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $216 |
| 2024-12-31 | $216 |
| 2023-12-31 | $125 |
Monte Rosa Therapeutics, Inc. Total Liabilities — FAQ
Monte Rosa Therapeutics, Inc. (GLUE) total liabilities over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GLUE's total liabilities history?
The chart and table above show Monte Rosa Therapeutics, Inc.'s total liabilities by year and by quarter, including the growth rate.